Literature DB >> 26719205

Part 4: Interaction between unproven cellular therapies and global medicinal product approval regulatory frameworks.

Karen Nichols1, William Janssen2, Dominic Wall3, Natividad Cuende4, Deborah Griffin5.   

Abstract

Year:  2016        PMID： 26719205     DOI： 10.1016/j.jcyt.2015.11.003

Source DB:  PubMed          Journal:  Cytotherapy        ISSN： 1465-3249            Impact factor:   5.414


× No keyword cloud information.
  2 in total

1.  Evaluation of the awareness of novel advanced therapies among family medicine residents in Spain.

Authors:  Miguel Sola; Carmen Sanchez-Quevedo; Miguel A Martin-Piedra; Victor Carriel; Ingrid Garzon; Jesus Chato-Astrain; Oscar-Dario Garcia-Garcia; Miguel Alaminos; Fernando Campos
Journal:  PLoS One       Date:  2019-04-03       Impact factor: 3.240

Review 2.  Science, ethics and communication remain essential for the success of cell-based therapies.

Authors:  Massimo Dominici; Karen M Nichols; Aaron D Levine; John Ej Rasko; Miguel Forte; Lynn O'Donnell; Mickey Bc Koh; Catherine M Bollard; Daniel J Weiss
Journal:  Brain Circ       Date:  2016-10-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.